Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker ▴	Company	Revenue	Net income	Net margin	Return on equity	Revenue growth	Diluted EPS
PHAT	Phathom Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$175.11M	-$221.25M	-126.3%	n/a	216.9%	-$3.03
PHIO	Phio Pharmaceuticals Corp. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$8.70M	n/a	-43.2%	n/a	n/a
PKTX	ProtoKinetix, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$393.6K	n/a	-132.1%	n/a	$0.00
PLRX	Pliant Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$149.34M	n/a	-82.4%	n/a	-$2.43
PLYX	Polaryx Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$8.98M	n/a	-196.8%	n/a	-$0.20
PMHS	Polomar Health Services, Inc. Manufacturing · Year ended 2025-12-31 · USD	$648.2K	-$10.70M	n/m	n/a	n/m	-$0.39
PMN	ProMIS Neurosciences Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$39.72M	n/a	n/a	n/a	-$22.61
PMVP	PMV Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$77.74M	n/a	-74.2%	n/a	-$1.48
PPCB	Propanc Biopharma, Inc. Manufacturing · Year ended 2026-06-30 · USD	n/a	-$18.86M	n/a	-200.6%	n/a	-$17.62
PRAX	Praxis Precision Medicines, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$303.27M	n/a	-34.5%	-100.0%	-$13.48
PRFX	PRF Technologies Ltd. Manufacturing · Year ended 2025-12-31 · USD	$17.0K	-$5.02M	n/m	-58.8%	n/a	-$7.47
PRGO	Perrigo Co PLC Manufacturing · Year ended 2025-12-31 · USD	$4.25B	-$1.43B	-33.5%	-48.6%	-2.8%	-$10.29
PRLD	Prelude Therapeutics Inc Manufacturing · Year ended 2025-12-31 · USD	$12.14M	-$99.50M	-819.6%	-145.0%	73.4%	-$1.29
PRPH	ProPhase Labs, Inc. Manufacturing · Year ended 2025-12-31 · USD	$4.34M	-$14.74M	-339.3%	-420.3%	-35.8%	-$1.74
PRTA	Prothena Corp Public Ltd Co Manufacturing · Year ended 2025-12-31 · USD	$9.68M	-$244.09M	n/m	-87.0%	-92.8%	-$4.53
PTCT	PTC Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.73B	$682.64M	39.4%	n/a	114.5%	$7.78
PTGX	Protagonist Therapeutics, Inc Manufacturing · Year ended 2025-12-31 · USD	$46.02M	-$130.15M	-282.8%	-21.2%	-89.4%	-$2.05
PTIX	Protagenic Therapeutics, Inc.\new Manufacturing · Year ended 2026-03-31 · USD	n/a	$1.37M	n/a	52.2%	n/a	$0.59
PTN	Palatin Technologies Inc Manufacturing · Year ended 2025-06-30 · USD	$0	-$17.31M	n/a	n/a	-100.0%	-$32.15
PTPI	Petros Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	$1.91M	n/a	66.7%	n/a	-$1.56
PULM	Pulmatrix, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$5.16M	n/a	-135.5%	n/a	-$1.41
PVCT	Provectus Biopharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$336.1K	-$5.43M	n/m	n/a	-45.5%	-$0.01
PVLA	Palvella Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$41.72M	n/a	-149.1%	n/a	-$3.71
PYXS	Pyxis Oncology, Inc. Manufacturing · Year ended 2025-12-31 · USD	$13.86M	-$79.62M	-574.5%	-149.1%	-14.2%	-$1.28
QNRX	Quoin Pharmaceuticals Ltd. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$15.80M	n/a	-120.5%	n/a	n/a

Rows per page: 2550 100